Nonclinical Development of ANX005: A Humanized Anti-C1q Antibody for Treatment of Autoimmune and Neurodegenerative Diseases

International Journal of Toxicology - United States
doi 10.1177/1091581817740873
Full Text
Abstract

Available in full text

Categories
Toxicology
Date
Authors
Publisher

SAGE Publications

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy